Mohamed Ali Daw, MD, PhD, FTCDI,MPS

Slides:



Advertisements
Similar presentations
Saotharlann Náisiúnta Tagartha Viris UCD UCD National Virus Reference Laboratory Dr. Jeff Connell Assistant Director National Virus Reference Laboratory.
Advertisements

Factors associated to the prevalence of antibodies to hepatitis C virus in chronic hemodialysis patients in a sample of centers in Puerto Rico, 2005 Marievelisse.
Prof. Fatma Amer Medical Microbiology and Immunology, ZAGAZIG FACULTY OF Medicine, Egypt President of ISC/HWG President of ArAPUA In the Era of Direct.
1 Lauren E. Finn, 2 Seth Sheffler-Collins, MPH, 2 Marcelo Fernandez-Viña, MPH, 2 Claire Newbern, PhD, 1 Dr. Alison Evans, ScD., 1 Drexel University School.
PREVAC B Management of hepatitis B prevention among migrants AASLD, San Francisco, 2008 AUBERT Jean-Pierre DI PUMPO Alexandrine SANTANA Pascale GERVAIS.
Seroprevalence of HBV and HCV among Children in the Kilimanjaro Region, Tanzania Florida J. Muro, Suzanne P. Fiorillo, Christopher Odhiambo, Coleen K.
World Hepatitis Day 2013, 29 th July Establishing a framework for better data collection and surveillance of Hepatitis in South Africa N. Prabdial-Sing.
PREVAC B Management of hepatitis B prevention among migrants AUBERT Jean-Pierre, DI PUMPO Alexandrine, SANTANA Pascale, MAJERHOLC Catherine, PY Anne-Marie,
Overview of Hepatitis B, C, and D Epidemiology in Eastern Europe and the Newly Independent States Michael O. Favorov MD, Ph.D., D.Sc. CDC Central Asia.
CHRONIC HEPATITIS B SEROLOGY. Antigens HBsAg -Found on the surface of the intact virus and in serum as unattached particles -Earliest detectable marker.
Africa Notes. North Africa Most important feature -Sahara desert Landscape mostly desert or mountains All countries border on Mediterranean Sea or Atlantic.
Need for vaccination for vaccine preventable hepatitis in methadone maintenance treatment Randy Seewald, MD 1,2,3, Eli Kamara, BS 2, Ruy Tio, DO 1,2, Rashiah.
July 2015 Core Epidemiology Slides.
A Universal Testing Programme for Blood Borne Viruses in an Urban Emergency Department – a call for widespread ED testing in Ireland S O’Connell 1, D Lillis.
Prevalence of hepatitis B and C viruses among human immunodeficiency virus infected children in Northern Nigeria. Pennap GRI, Yahuza, AJ and Abdulkarim,
The name of your presentationYour logo Your presentation name Your name Your institution.
Serologic markers and molecular epidemiology of HBV from an HIV infected cohort from Cameroon Tshifhiwa Magoro 1, Emmaculate Nongpang 2, Lufuno Mavhandu.
Core Epidemiology Slides
Global summary of the HIV and AIDS epidemic, December 2003
LOW HCV PREVALENCE AMONG HIV+ INDIVIDUALS IN SUB-SAHARAN AFRICA
Epidemiology of hepatitis B in Ireland Last updated March 2017
Migration from Africa to Europe sub-Saharan Africa
In The Name of God.
Table 3 Titers of antibody to hepatitis B surface antigen (anti-HBs) 2–4 weeks after the first vaccination From: Response to Hepatitis B Vaccine in HIV-1–Positive.
Mesfin S. Mulatu, Ph.D., M.P.H. The MayaTech Corporation
Global summary of the AIDS epidemic, December 2007
Aminu M and Okpe Sunday Ejeh
Global summary of the HIV/AIDS epidemic, December 2003
Dr Iyat Abdul Sattar A study on the clinical & serolological markers of HBV among patients with chronic HBV infection in Babylon Dr Monem Makki Alshok.
Global summary of the AIDS epidemic, 2008
Knowledge of transmission Sharing of sharp objects
Mohamed Ali Daw, MD, PhD, FTCDI,MPS
Tracking Legacy Radionuclides in St
Global summary of the HIV/AIDS epidemic, December 2003
Mohamed Ali Daw, MD, PhD, FTCDI,MPS
Global summary of the AIDS epidemic, 2008
The country with the largest population in Africa is
Vrushali Patwardhan, Dinesh Kumar, Varun Goel, Sarman Singh
Global burden of HIV, viral hepatitis and TB in prisoners
Global epidemiology of injecting drug use
HCV-Geographic integration; An Epidemiological Phenomenon Could it be Approved ? This is your introductory slide – use it to introduce yourself and your.
DOES HIV/ HEPATITIS COINFECTION AFFECT PEOPLE ACCESSING CARE FOR HIV
No conflict of interest to declare
R. Cavallo  Clinical Microbiology and Infection 
WHO HIV update July 2018 Global epidemic Global progress and cascade
Hepatitis B in People of African Origin
Regional HIV and AIDS statistics and features, 2003 and 2005
Global summary of the HIV and AIDS epidemic, December 2004
Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections.
Division of Viral Hepatitis
Introduction The American Journal of Medicine
Africa Map Study Guide.
How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B. Time for an individualised approach?  Neil Rajoriya,
Sero-epidemiologic study on Foot-and-Mouth Disease in livestock in West Libya Symaia M. AbdulJawad1, Hiyam M. Zegallai1, Emad M. Bennour2, Ibrahim M.
HIV and viral hepatitis knowledge and information needs among migrants from sub-Saharan Africa residing in Germany – results of a multi-center cross-sectional.
Global summary of the AIDS epidemic, December 2007
By: Antehun Alemayehu (M.Sc)
The country with the largest population in Africa is
Global summary of the HIV/AIDS epidemic, December 2003
Global summary of the HIV and AIDS epidemic, 2005
A CASE SERIES OF DISCORDANT LABORATORY RESULTS WITH RAPID HIV TESTING
Summary Sheet Figures and Maps
Regional HIV and AIDS statistics and features, end of 2004
Global summary of the HIV and AIDS epidemic, 2005
Provider comparison reveals no difference between training levels
Core epidemiology slides
July 2018 Core epidemiology slides.
09/10/2019 Healthcare utilisation in the country of origin among immigrants in Denmark: the role of trust in the Danish healthcare system Authors: María.
Assessment of risk factors for hepatocellular carcinoma in HIV care and treatment programs across 31 countries: a cross-sectional survey within IeDEA C.
Share your thoughts on this presentation with #IAS2019
Presentation transcript:

Mohamed Ali Daw, MD, PhD, FTCDI,MPS Epidemiology of Hepatitis B Virus in Immigrants Crossing to Europe from North and Sub-Saharan Africa This is your introductory slide – use it to introduce yourself and your paper Mohamed Ali Daw, MD, PhD, FTCDI,MPS Department of Medical Microbiology &Immunology, Faculty of Medicine, Tripoli-LIBYA

Summary A 14205 serum samples were collected from African immigrants coming from North and Sub-Saharan Africa resided in Tripoli-Libya (2013-2015) The total anti-core antibodies (anti-HBc), the surface antigen (HBsAg) and the protective anti-surface antigen antibodies (anti-HBs) were measured using immunoenzymatic assays . The data was correlated with demographic and potential risk factors within the recruited individuals. Replace this box with an image Provide a summary of your main findings, and the major relevant points. If possible, include an image that illustrates your research.

Why this study is important ? A rare study highlighting the status HBV infections among immigrants before the final settlement in EU countries The study could be used as a vehicle for further understanding to the epidemiology of HBV in African countries which rarely studied. This is more likely to influence EU countries health care system regarding viral screening and guide lines HIV infection Explain the importance and relevance of your research, putting it in context.

Background Sub-Saharan Africa have been considered to harbor the highest prevalence of HIV. Mass migration has been on the upswing in recent years particularly from North and sub-Saharan Africa. HBV infections among African immigrants are rarely studied particularly before resettlement. The study aimed to determine 1-the prevalence of HBV among African immigrants gather in Libya on their way to Europe 2- HBV-HIV-HCV coinfection and genotypes among HIV infected immigrants and its correlation different demographic factors. Provide additional information or references, or add an image or figure here Provide relevant background information that helps elucidate your findings.

Methods Population studied Region/Country No. of immigrants/Year Sample size (%) Ratio* 2013 2014 2015 Central Africa   Chad 379 978 1200 2557 1:6 Central Africa total 2557 (18) West Africa Burkina Faso/Ivory Coast 160 177 230 567 1:25 Niger /Mali 750 1038 1687 3475 1:4 Nigeria/Ghana 300 305 346 951 1:13 West Africa total 1210 1520 2263 4993 (35.2) 1:3 Horn of Africa (East Africa) Eritrea 320 250 227 797 1:18 Somalia 660 715 637 2012 1:7 Ethiopia 270 215 1:20 East Africa total 1250 1195 1097 3.524 (24.8) North Africa Nile River Region Egypt 326 153 138 617 1:23 Sudan 459 580 859 1898 Maghreb Region Maghreb countries ** 238 197 181 616 North Africa total 1023 930 1178 3131 (22) Total 3862 (27.2) 4623 (32.5) 5720 (40.3) 14205 Present your main methods: in a nutshell, what did you do?

Results The prevalence of HBV and HBV co-infections (HCV and HIV) in African immigrants crossing to Europe from North and Sub-Saharan Africa;2013-2015 Region/Country Serological status, no (%) HBV/HCV Co-infection HBV/HIV co-infection Sample size (%) HBs Ag positive HBs Ag negative/anti-HBc positive Central Africa   Chad 2557 325 (12.7) 1401(54.8) 133(5.2) 8(0.3) Central Africa total 2557(18) 325(12.7 ) 133 (5.2) 8 (0.3) West Africa Burkina Faso/Ivory Coast 567 78(13.8) 336(59.3) 47 (8.3) 17(2.9) Niger /Mali 3475 400(11.5) 1859(53.5) 222 (6.4) 14(0.4) Nigeria/Ghana 951 135(14.2 ) 544(57.2) 75(7.9) 20(2.1) West Africa total 4993 (35.2) 613 (12.3) 2793(54.9) 344(6.9) 51(1.0) Horn of Africa (East Africa) Eritrea 797 98(12.3) 264 (33.1) 28 ( 3.5) 6(0.8) Somalia 2012 374(18.6) 296 (14.7) 97(4.8) 8(0.4) Ethiopia 715 105(14.7) 370 (51.7) 44 (6.2) 9(1.3) East Africa total 3524 (24.8) 577(16.4) 930(26.4) 169(4.8) 23(0.7) North Africa Nile River Region Egypt 617 40(6.5) 94(15.2) 91(14.7) 1(0.1) Sudan 1898 158 (8.3) 791(41.7) 55(2.9) 6(0.3) Maghreb Region Maghreb countries ** 616 32 (5.2) 104 (16.9) 19(3.1) 1(0.2) North Africa total 3131 (22) 230(7.3) 989((31.6) 165(5.3) Total 14205 1745(12.3) 6113(43.0) 811(5.7) 90(0.6) frame) Talk through your results – what stood out? What surprised you?

Continue to describe your results on this second slide if you need more time.

Concepts and future steps A higher prevalence of HBV and HIV-HCV co-infections with distinct variation among immigrants. Further studies on following up the epidemiology of HBV among immigrants during final resettlement are needed. Neoliberal policies of HBV prevention should be introduced and extended beyond the European borders to reach Africa Provide additional information, or add an image or figure here Talk about next steps and future work. Where do your conclusions lead? If you’ve worked on a medical treatment or product, what’s the next step in its development? Are you working on a related but different project? Here’s the place to point readers to your new research.